Log in
Enquire now
‌

US Patent 10544141 Derivatives and methods of treating hepatitis B infections

Patent 10544141 was granted and assigned to Novira Therapeutics on January, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Novira Therapeutics
Novira Therapeutics
Current Assignee
Novira Therapeutics
Novira Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10544141
Patent Inventor Names
Scott Kuduk0
George D. Hartman0
Date of Patent
January 28, 2020
Patent Application Number
16118760
Date Filed
August 31, 2018
Patent Citations Received
‌
US Patent 10975077 Diazepinone derivatives and their use in the treatment of hepatitis B infections
‌
US Patent 10987359 Oxadiazepinone derivatives and methods of treating hepatitis B infections
0
Patent Primary Examiner
‌
Heidi Reese
Patent abstract

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10544141 Derivatives and methods of treating hepatitis B infections

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.